NASDAQ:CRDL
Cardiol Therapeutics Inc.
- Stock
locale
Canadamarket
STOCKSindustry
Drug Manufacturers - Specialty & Genericwebsite
www.cardiolrx.comipo date
Dec 20, 2018
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate the efficacy and safety of Cardiol...Show More
Earnings
Earnings Release in 13 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus